AU2001223910A1 - Interferon-alpha use in the treatment of ewing's family of tumors - Google Patents

Interferon-alpha use in the treatment of ewing's family of tumors

Info

Publication number
AU2001223910A1
AU2001223910A1 AU2001223910A AU2391001A AU2001223910A1 AU 2001223910 A1 AU2001223910 A1 AU 2001223910A1 AU 2001223910 A AU2001223910 A AU 2001223910A AU 2391001 A AU2391001 A AU 2391001A AU 2001223910 A1 AU2001223910 A1 AU 2001223910A1
Authority
AU
Australia
Prior art keywords
ewing
interferon
tumors
family
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001223910A
Other languages
English (en)
Inventor
Josiane Sanceau
Jeanne Wietzerbin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Institut Curie filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2001223910A1 publication Critical patent/AU2001223910A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001223910A 2000-01-19 2001-01-18 Interferon-alpha use in the treatment of ewing's family of tumors Abandoned AU2001223910A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00400132 2000-01-19
EP00400132A EP1118330A1 (de) 2000-01-19 2000-01-19 Verwendung von Alpha Interferon zur Behandlung von Ewings Tumoren
PCT/IB2001/000044 WO2001052881A1 (en) 2000-01-19 2001-01-18 Interferon-alpha use in the treatment of ewing's family of tumors

Publications (1)

Publication Number Publication Date
AU2001223910A1 true AU2001223910A1 (en) 2001-07-31

Family

ID=8173514

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001223910A Abandoned AU2001223910A1 (en) 2000-01-19 2001-01-18 Interferon-alpha use in the treatment of ewing's family of tumors

Country Status (7)

Country Link
EP (2) EP1118330A1 (de)
AR (1) AR024823A1 (de)
AT (1) ATE265223T1 (de)
AU (1) AU2001223910A1 (de)
DE (1) DE60103016T2 (de)
ES (1) ES2220704T3 (de)
WO (1) WO2001052881A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153584A1 (de) * 2001-11-02 2003-05-15 Megamedics Gmbh Verfahren zur Indentifizierung Tumor-spezifischer Antigene auf Krebszellen
RU2482871C2 (ru) * 2010-06-07 2013-05-27 Общество с ограниченной ответственностью "Центр Инновационных Технологий "БиоФарм" (ООО "ЦИТ "БиоФарм") Композиция для лечения вирусных заболеваний животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2308373A1 (en) * 1997-11-07 1999-05-20 Mayo Foundation For Medical Education And Research Interferon immunotherapy

Also Published As

Publication number Publication date
DE60103016D1 (de) 2004-06-03
EP1250147B1 (de) 2004-04-28
ATE265223T1 (de) 2004-05-15
AR024823A1 (es) 2002-10-30
ES2220704T3 (es) 2004-12-16
DE60103016T2 (de) 2005-04-07
EP1118330A1 (de) 2001-07-25
EP1250147A1 (de) 2002-10-23
WO2001052881A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
EP1392287B8 (de) Verwendung von substituierten Azetidinonderivaten in der Behandlung der Alzheimer-Krankheit
IL205242A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
GB0106183D0 (en) Improvements in or relating to the treatment of lesions
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU5845099A (en) Use of (pex) in the treatment of metabolic bone diseases
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
AU2002212471A1 (en) Peptides for use in the treatment of alzheimer's disease
HUP0203811A3 (en) Use of polymeric material in the treatment of hard surfaces
IL160018A0 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
AU2002243363A1 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
AU5262200A (en) Arrangement in ventilatory treatment of the lungs
AU4789099A (en) Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
HUP0400262A3 (en) Glycopeptides, their preparation and use in the treatment of multiple sclerosis
PL354412A1 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
AU2001253886A1 (en) Methylxanthines in the diagnosis and treatment of autistic disorder
AU2001223910A1 (en) Interferon-alpha use in the treatment of ewing's family of tumors
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU3061199A (en) Skin treatment compositions and the use thereof
AU2001285026A1 (en) Methods and compositions for use in the diagnosis and treatment of chronic immune disease